Angiotensin II-mediated hippocampal hypoperfusion and vascular dysfunction contribute to vascular cognitive

Olivia Gannon1, Sarah M Tremble1, Conor McGinn1

  • 1Department of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.

Insights

Chronic hypertension impairs memory by affecting hippocampal arterioles. Captopril treatment improved blood flow and memory in aged hypertensive rats, suggesting a therapeutic target.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Gerontology

Background:

  • Chronic hypertension is a major risk factor for vascular cognitive impairment (VCI).
  • The specific mechanisms by which hypertension impacts hippocampal vasculature and contributes to VCI are not fully understood.

Purpose of the Study:

  • To investigate the effects of hypertension on hippocampal arteriole (HA) function, hippocampal perfusion, and memory.
  • To explore the role of angiotensin II signaling in hypertension-induced cognitive decline.

Main Methods:

  • Studied memory, HA function, and perfusion in Wistar rats and spontaneously hypertensive rats (SHR) at different ages.
  • Treated aged SHR with captopril or apocynin to assess therapeutic effects.

Main Results:

  • Aged SHR exhibited impaired memory, HA endothelial dysfunction, and reduced hippocampal blood flow (~50%).
  • Captopril treatment improved HA function, restored perfusion, and rescued memory in aged SHR.
  • Apocynin treatment did not yield significant improvements.

Conclusions:

  • Hippocampal vascular dysfunction, driven by angiotensin II signaling, contributes to memory decline in hypertension.
  • Targeting hippocampal arterioles offers a potential therapeutic strategy for preserving neurocognitive health in aging hypertensive individuals.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
677
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
652